1. Home
  2. KRYS vs CVLT Comparison

KRYS vs CVLT Comparison

Compare KRYS & CVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • CVLT
  • Stock Information
  • Founded
  • KRYS 2015
  • CVLT 1996
  • Country
  • KRYS United States
  • CVLT United States
  • Employees
  • KRYS N/A
  • CVLT N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • CVLT Computer Software: Prepackaged Software
  • Sector
  • KRYS Health Care
  • CVLT Technology
  • Exchange
  • KRYS Nasdaq
  • CVLT Nasdaq
  • Market Cap
  • KRYS 6.3B
  • CVLT 6.1B
  • IPO Year
  • KRYS 2017
  • CVLT 2006
  • Fundamental
  • Price
  • KRYS $221.08
  • CVLT $123.43
  • Analyst Decision
  • KRYS Strong Buy
  • CVLT Buy
  • Analyst Count
  • KRYS 9
  • CVLT 12
  • Target Price
  • KRYS $214.22
  • CVLT $194.18
  • AVG Volume (30 Days)
  • KRYS 335.7K
  • CVLT 833.3K
  • Earning Date
  • KRYS 11-03-2025
  • CVLT 10-28-2025
  • Dividend Yield
  • KRYS N/A
  • CVLT N/A
  • EPS Growth
  • KRYS 275.72
  • CVLT N/A
  • EPS
  • KRYS 6.66
  • CVLT 1.76
  • Revenue
  • KRYS $373,164,000.00
  • CVLT $1,095,835,000.00
  • Revenue This Year
  • KRYS $34.33
  • CVLT $19.22
  • Revenue Next Year
  • KRYS $48.04
  • CVLT $12.22
  • P/E Ratio
  • KRYS $32.83
  • CVLT $70.05
  • Revenue Growth
  • KRYS 54.51
  • CVLT 22.02
  • 52 Week Low
  • KRYS $122.80
  • CVLT $116.33
  • 52 Week High
  • KRYS $221.84
  • CVLT $200.69
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 76.21
  • CVLT 33.27
  • Support Level
  • KRYS $203.17
  • CVLT $116.33
  • Resistance Level
  • KRYS $212.97
  • CVLT $123.21
  • Average True Range (ATR)
  • KRYS 7.05
  • CVLT 4.47
  • MACD
  • KRYS 0.96
  • CVLT 1.29
  • Stochastic Oscillator
  • KRYS 98.60
  • CVLT 43.67

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About CVLT Commvault Systems Inc.

CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Cleanroom Recovery, HyperScale X, Air Gap Protect, Compliance, Cloud Rewind, and Clumio Backtrack. The company operates in the United States and exports to many other countries.

Share on Social Networks: